We are live on !
Find out more
RegentAtlantic Capital Portfolio holdings
AUM
$3.34B
Turnover
11.52%
1-Year Est. Return
14.54%
This Fund
S&P 500
This Quarter Est. Return
-5.78%
1 Year Est. Return
-14.54%
3 Year Est. Return
+23.47%
5 Year Est. Return
+45.3%
10 Year Est. Return
–
AUM
$3.34B
AUM Growth
+$309M
(+10%)
Cap. Flow
+$561M
Cap. Flow % of AUM
Cap. Flow %
16.78%
Top 10 Holdings %
Top 10 Hldgs %
45.09%
Holding
712
New
36
Increased
289
Reduced
298
Closed
46
Avg Time Held
4.3
years
Top 10 Avg Time Held
2.2
years
Top 20 Avg Time Held
2.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$215M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$87.7M |
| 3 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$79.1M |
| 4 |
Vanguard Real Estate ETF
VNQ
|
+$70.1M |
| 5 |
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
|
+$36.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Small-Cap ETF
IJR
|
+$67.8M |
| 2 |
iShares Micro-Cap ETF
IWC
|
+$8.07M |
| 3 |
State Street SPDR Portfolio S&P 500 Value ETF
SPYV
|
+$5.06M |
| 4 |
Golub Capital BDC
GBDC
|
+$4.69M |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$4.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 47.99% |
| 2 | Technology | 13.24% |
| 3 | Healthcare | 8.59% |
| 4 | Financials | 6.84% |
| 5 | Consumer Discretionary | 5.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Vanguard S&P 500 ETF
VOO
$1.04T
| $374M | 11.19% |
1,139,076
+588,822
| +107% | +$215M |
2018 Q3
16 quarters
|
|
2
Schwab International Equity ETF
SCHF
$67.5B
| $309M | 9.23% |
21,948,372
-93,808
| -0.4% | -$1.47M |
2019 Q1
14 quarters
|
|
3
Apple
AAPL
$4.95T
| $134M | 4% |
966,669
+31,473
| +3% | +$4.94M |
2013 Q2
37 quarters
|
|
|
4
Vanguard Real Estate ETF
VNQ
$37B
| $120M | 3.59% |
1,498,516
+749,451
| +100% | +$70.1M |
2019 Q3
12 quarters
|
|
|
5
Vanguard FTSE Developed Markets ETF
VEA
$229B
| $116M | 3.46% |
3,177,386
+1,940,110
| +157% | +$79.1M |
2019 Q3
12 quarters
|
|
6
iShares Core MSCI Emerging Markets ETF
IEMG
$152B
| $110M | 3.29% |
2,561,636
-39,755
| -2% | -$1.91M |
2014 Q4
31 quarters
|
|
7
Invesco S&P 500 Pure Value ETF
RPV
$1.69B
| $102M | 3.04% |
1,456,994
+77,899
| +6% | +$5.99M |
2022 Q1
2 quarters
|
|
8
Microsoft
MSFT
$3.95T
| $94.1M | 2.82% |
404,124
-10,003
| -2% | -$2.64M |
2013 Q2
37 quarters
|
|
|
9
Schwab US Dividend Equity ETF
SCHD
$116B
| $85.7M | 2.56% |
3,872,442
+3,610,767
| +1,380% | +$87.7M |
2019 Q3
12 quarters
|
|
10
Vanguard Morningstar Growth ETF
VUG
$229B
| $63.8M | 1.91% |
1,787,892
+856,476
| +92% | +$34.4M |
2020 Q2
9 quarters
|
|
11
Alphabet (Google) Class A
GOOGL
$4.16T
| $52M | 1.56% |
544,108
-4,232
| -0.8% | -$469K |
2015 Q4
27 quarters
|
|
12
Amazon
AMZN
$2.83T
| $43.1M | 1.29% |
381,195
+75,671
| +25% | +$9.6M |
2014 Q3
32 quarters
|
|
13
State Street SPDR S&P 500 ETF Trust
SPY
$820B
| $38M | 1.14% |
106,354
+343
| +0.3% | +$136K |
2013 Q2
37 quarters
|
|
14
ExxonMobil
XOM
$731B
| $37.4M | 1.12% |
428,596
+219,736
| +105% | +$20.1M |
2013 Q2
37 quarters
|
|
|
15
Goldman Sachs Access Treasury 0-1 Year ETF
GBIL
$7.92B
| $36.6M | 1.09% |
+366,271
| New | +$36.6M |
2022 Q3
0 quarters
|
|
16
Tesla
TSLA
$1.48T
| $35.1M | 1.05% |
132,250
+12,490
| +10% | +$3.49M |
2018 Q2
17 quarters
|
|
17
Johnson & Johnson
JNJ
$625B
| $34.9M | 1.04% |
213,405
+1,794
| +0.8% | +$304K |
2013 Q2
37 quarters
|
|
18
iShares Core S&P Mid-Cap ETF
IJH
$123B
| $33M | 0.99% |
752,185
-510
| -0.1% | -$24.7K |
2013 Q4
35 quarters
|
|
19
UnitedHealth
UNH
$376B
| $30.8M | 0.92% |
60,895
-2,249
| -4% | -$1.18M |
2013 Q2
37 quarters
|
|
20
Berkshire Hathaway Class B
BRK.B
$1.16T
| $30.3M | 0.91% |
113,359
-727
| -0.6% | -$207K |
2013 Q2
37 quarters
|
|
21
Vanguard FTSE Emerging Markets ETF
VWO
$123B
| $27.8M | 0.83% |
760,970
+584,669
| +332% | +$23.7M |
2018 Q3
16 quarters
|
|
22
Walmart Inc
WMT
$935B
| $23.1M | 0.69% |
534,822
+266,934
| +100% | +$11.7M |
2013 Q2
37 quarters
|
|
23
Thermo Fisher Scientific
TMO
$254B
| $21.2M | 0.63% |
41,755
-458
| -1% | -$256K |
2013 Q2
37 quarters
|
|
24
Elevance Health
ELV
$95.5B
| $20.1M | 0.6% |
44,315
-726
| -2% | -$347K |
2013 Q2
37 quarters
|
|
25
Pfizer
PFE
$172B
| $19.3M | 0.58% |
440,788
-9,651
| -2% | -$469K |
2013 Q2
37 quarters
|
|
Similar funds
APA
RegentAtlantic Capital's Q3 2022 Portfolio in Review
As of Q3 2022, RegentAtlantic Capital held 712 positions worth $3.34B, up 10% from $3.03B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
RegentAtlantic Capital deployed $561M of net new capital in Q3 2022, opening 36 new positions and adding to 289 existing holdings. Its largest new stake was Goldman Sachs Access Treasury 0-1 Year ETF: 366,271 shares worth $36.6M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, up from 41% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P Small-Cap ETF, an estimated $67.8M trimmed.
- RegentAtlantic Capital's largest Q3 2022 buy was Goldman Sachs Access Treasury 0-1 Year ETF: 366,271 shares worth $36.6M.
- RegentAtlantic Capital added most to Vanguard S&P 500 ETF in Q3 2022, an estimated $215M increase.
- RegentAtlantic Capital's biggest Q3 2022 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $67.8M.
- RegentAtlantic Capital fully exited iShares MSCI Emerging Markets ex China ETF in Q3 2022, selling an estimated $4.23M.
- RegentAtlantic Capital's ten largest holdings make up 45% of its $3.34B portfolio in Q3 2022.
- RegentAtlantic Capital opened 36 new positions and closed 46 in Q3 2022.
- RegentAtlantic Capital's portfolio value rose 10% quarter-over-quarter to $3.34B.
Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.